Table 1 Result of the generation of resistant parasites to KAE609, DONE3TCl and YAT2150. *: parasites were not detected during the experiment when compound concentration was increased. **: no parasites re-emerged at day 60 upon treatment with one single lethal dose.

From: YAT2150 is irresistible in Plasmodium falciparum and active against Plasmodium vivax and Leishmania clinical isolates

Compound

Number of initial parasites (compound concentration)

Method

Day of reemergence

Number of reemerged replicates

KAE609

1 × 10⁸ (3×IC50)

Lethal dose

17

3

KAE609

1 × 10⁹ (3×IC50)

Lethal dose

15

3

DONE3TCl

1 × 10⁸ (3×IC50)

Lethal dose

28

1

DONE3TCl

1 × 10⁹ (3×IC50)

Lethal dose

30

3

DONE3TCl

1 × 10⁸ (1×IC50)

Stepwise increased sub-lethal doses

*

0

YAT2150

1 × 10⁸ (3×IC50)

Lethal dose

**

0

YAT2150

1 × 10⁹ (3×IC50)

Lethal dose

**

0

YAT2150

1 × 10⁸ (1×IC50)

Stepwise increased sub-lethal doses

*

0

YAT2150

1 × 10⁸ (0.5×IC50)

Stepwise increased sub-lethal doses

*

0

YAT2150

1 × 10⁸ (0.25×IC50)

Stepwise increased sub-lethal doses

*

0